Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of 83.10% is 76% above its 5-year average of 47.11%, near the high end of its 5-year range (42.36%–83.10%).
As of the fiscal period ended Tuesday, June 30, 2026. 19.85% above its 12-month average of 69.34%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation.
RETURN ON EQUITY (ROE)
83.10%
RETURN ON EQUITY (ROE) AVG TTM
69.34%
RETURN ON EQUITY (ROE) AVG 3Y
48.84%
RETURN ON EQUITY (ROE) AVG 5Y
47.11%
RETURN ON EQUITY (ROE) AVG 10Y
49.83%
RETURN ON EQUITY (ROE) AVG 15Y
48.42%
RETURN ON EQUITY (ROE) AVG 20Y
N/A
CURRENT VS TTM AVG
+19.85%
CURRENT VS 3Y AVG
+70.16%
CURRENT VS 5Y AVG
+76.40%
CURRENT VS 10Y AVG
+66.78%
CURRENT VS 15Y AVG
+71.63%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
13.01%
median of 84 covered companies
CURRENT VS SECTOR MEDIAN
+538.74%
vs the sector median at left
Zoetis Inc.
Market Cap
$30.86B
Return on Equity (ROE)
83.10%
TTM Avg
69.34%
3Y Avg
48.84%
5Y Avg
47.11%
Market Cap
$31.40B
Return on Equity (ROE)
4.43%
TTM Avg
8.42%
3Y Avg
11.86%
5Y Avg
16.52%
Market Cap
$30.16B
Return on Equity (ROE)
14.51%
TTM Avg
21.84%
3Y Avg
21.53%
5Y Avg
32.27%
Market Cap
$30.13B
Return on Equity (ROE)
1.09%
TTM Avg
29.98%
3Y Avg
64.02%
5Y Avg
111.55%
Market Cap
$31.90B
Return on Equity (ROE)
38.14%
TTM Avg
28.93%
3Y Avg
25.01%
5Y Avg
22.95%
Market Cap
$31.90B
Return on Equity (ROE)
-22.60%
TTM Avg
-10.46%
3Y Avg
-1.37%
5Y Avg
1.10%
Market Cap
$32.06B
Return on Equity (ROE)
23.13%
TTM Avg
23.30%
3Y Avg
22.33%
5Y Avg
21.49%
Market Cap
$29.33B
Return on Equity (ROE)
5.97%
TTM Avg
9.02%
3Y Avg
4.86%
5Y Avg
4.86%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Zoetis Inc. (ZTS) | $30.86B | 83.10% | 69.34% | 48.84% | 47.11% |
| Biogen Inc. (BIIB)vs › | $31.40B | 4.43% | 8.42% | 11.86% | 16.52% |
| GE HealthCare Technologies Inc. (GEHC)vs › | $30.16B | 14.51% | 21.84% | 21.53% | 32.27% |
| Waters Corporation (WAT)vs › | $30.13B | 1.09% | 29.98% | 64.02% | 111.55% |
| DexCom, Inc. (DXCM)vs › | $31.90B | 38.14% | 28.93% | 25.01% | 22.95% |
| Centene Corp. (CNC)vs › | $31.90B | -22.60% | -10.46% | -1.37% | 1.10% |
| ResMed Inc. (RMD)vs › | $32.06B | 23.13% | 23.30% | 22.33% | 21.49% |
| Medline Inc. (MDLN)vs › | $29.33B | 5.97% | 9.02% | 4.86% | 4.86% |
| Alcon Inc. (ALC)vs › | $33.71B | 2.96% | 4.58% | 3.90% | 2.45% |
| Alnylam Pharmaceuticals, Inc. (ALNY)vs › | $34.80B | 59.67% | -187.43% | 134.89% | 51.69% |
ROE
83.1%
ROA
17.4%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | 83.10% |
| 2026-03-31 | 81.75% |
| 2025-12-31 | 80.25% |
| 2025-09-30 | 49.11% |
| 2025-06-30 | 52.48% |
| 2025-03-31 | 54.09% |
| 2024-12-31 | 52.12% |
| 2024-09-30 | 46.43% |
| 2024-06-30 | 47.20% |
| 2024-03-31 | 47.27% |
| 2023-12-31 | 46.91% |
| 2023-09-30 | 44.90% |
| 2023-06-30 | 47.85% |
| 2023-03-31 | 46.08% |
| 2022-12-31 | 47.99% |
| 2022-09-30 | 44.33% |
| 2022-06-30 | 45.63% |
| 2022-03-31 | 44.50% |
| 2021-12-31 | 44.84% |
| 2021-09-30 | 42.36% |
| 2021-06-30 | 43.89% |
| 2021-03-31 | 43.38% |
| 2020-12-31 | 43.46% |
| 2020-09-30 | 46.17% |
| 2020-06-30 | 54.23% |
| 2020-03-31 | 58.52% |
| 2019-12-31 | 55.39% |
| 2019-09-30 | 54.56% |
| 2019-06-30 | 57.03% |
| 2019-03-31 | 59.91% |
| 2018-12-31 | 65.35% |
| 2018-09-30 | 54.96% |
| 2018-06-30 | 56.60% |
| 2018-03-31 | 49.90% |
| 2017-12-31 | 48.81% |
| 2017-10-01 | 47.11% |
| 2017-07-02 | 51.20% |
| 2017-04-02 | 53.14% |
| 2016-12-31 | 55.21% |
| 2016-10-02 | 43.47% |
| 2016-07-03 | 47.09% |
| 2016-04-03 | 32.45% |
| 2015-12-31 | 31.74% |
| 2015-09-27 | 36.05% |
| 2015-06-28 | 35.71% |
| 2015-03-29 | 46.40% |
| 2014-12-31 | 44.47% |
| 2014-09-28 | 41.20% |
| 2014-06-29 | 41.83% |
| 2014-03-30 | 48.19% |
| 2013-12-31 | 53.62% |
| 2013-09-29 | 46.14% |
| 2013-06-30 | 52.50% |
| 2013-03-31 | 65.59% |
| 2012-12-31 | 10.83% |
| 2012-09-30 | 11.11% |
| 2012-06-30 | 9.89% |
| 2012-03-31 | 7.12% |
| 2011-12-31 | 6.59% |
